CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 9.46: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.57BCNY382.95M · vs all stocks (USD)
Revenue (TTM)
331.61MCNY49.48M · vs all stocks (USD)
Profit Margin
-4.38%vs Medical Instruments & Supplies peers
Beta
0.5140xvs all stocks
52-Week Change
-31.24%vs all stocks
Market Capitalization
2.57BCNY382.95M · vs all stocks (USD)
Enterprise Value
2.58BCNY384.64M · vs all stocks (USD)
Price to Sales (TTM)
7.74xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.90xvs Medical Instruments & Supplies peers
Enterprise to Revenue
7.77xvs Medical Instruments & Supplies peers
Gross Margin
64.92%vs Medical Instruments & Supplies peers
Profit Margin
-4.38%vs Medical Instruments & Supplies peers
Operating Margin
-8.70%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-1.23%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-2.78%vs Medical Instruments & Supplies peers
Revenue (TTM)
331.61MCNY49.48M · vs all stocks (USD)
Revenue per Share (TTM)
2.63CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-14.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
228.37MCNY34.08M · vs all stocks (USD)
EBITDA (TTM)
-1.77MCNY-263.68K · vs all stocks (USD)
Net Income (TTM)
-14.53MCNY-2.17M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
24.11%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
37.77MCNY5.64M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
34.74MCNY5.18M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
12.23MCNYFY2025 · Dec 31, 2025Revenue
342.02MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
107.94MCNYFY2025 · Dec 31, 2025Gross Profit
234.07MCNYFY2025 · Dec 31, 2025Operating Income
-25.89MCNY-3.86M · vs all stocks (USD)
Pre-tax Income
-26.08MCNYFY2025 · Dec 31, 2025Income Tax Expense
747.37KCNYFY2025 · Dec 31, 2025Net Income
-26.83MCNYFY2025 · Dec 31, 2025EBIT
-22.83MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-1.62MCNYFY2025 · Dec 31, 2025Research & Development
40.56MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
138.66MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
497.51KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.26MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1906CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1906CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
126.03MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
126.03MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-26.83MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.81MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-8.69MCNYFY2025 · Dec 31, 2025Free Cash Flow
-16.93MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
159.62MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-26.83MCNYFY2025 · Dec 31, 2025Other Non-cash Items
7.24MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
7.02MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
3.88MCNYFY2025 · Dec 31, 2025Capital Expenditures
-8.23MCNYFY2025 · Dec 31, 2025Net Acquisitions
-13.06MCNYFY2025 · Dec 31, 2025Purchase of Investments
-42.50MCNYFY2025 · Dec 31, 2025Other Investing Activity
2.96MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-60.84MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
93.60MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-58.40MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-10.13MCNYFY2025 · Dec 31, 2025Other Financing Charges
-8.59MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
16.49MCNYFY2025 · Dec 31, 2025Shares Outstanding
126.05MSharesUpdated Sep 21, 2026Float Shares
74.29MSharesUpdated Sep 21, 2026% Held by Insiders
41.71%vs all stocks
% Held by Institutions
6.06%vs all stocks
Total Cash (MRQ)
83.95MCNY12.53M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6660CNYUpdated Sep 21, 2026Total Debt (MRQ)
84.97MCNY12.68M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1272xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
3.08xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
5.22CNYUpdated Sep 21, 2026Total Assets
859.71MCNY128.29M · vs all stocks (USD)
Total Current Assets
396.56MCNYFY2025 · Dec 31, 2025Total Liabilities
180.03MCNYFY2025 · Dec 31, 2025Total Non-current Assets
463.15MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
26.75MCNYFY2025 · Dec 31, 2025Total Current Liabilities
153.28MCNYFY2025 · Dec 31, 2025Cash
160.19MCNYFY2025 · Dec 31, 2025Cash Equivalents
4.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
164.60MCNYFY2025 · Dec 31, 2025Accounts Receivable
139.73MCNYFY2025 · Dec 31, 2025Inventory
57.29MCNYFY2025 · Dec 31, 2025Accounts Payable
13.54MCNYFY2025 · Dec 31, 2025Short-term Debt
93.45MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.54MCNYFY2025 · Dec 31, 2025Long-term Debt
25.14MCNYFY2025 · Dec 31, 2025Common Stock (Book)
126.05MCNYFY2025 · Dec 31, 2025Retained Earnings
156.69MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
679.67MCNY101.42M · vs all stocks (USD)
52-Week Low
16.91CNYUpdated Sep 21, 202652-Week High
44.12CNYUpdated Sep 21, 202652-Week Change
-31.24%vs all stocks
Beta
0.5140xvs all stocks
50-Day MA
21.80CNYUpdated Sep 21, 2026200-Day MA
26.87CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.47MSharesUpdated Sep 21, 2026Avg 30-Day Volume
7.86MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
-0.1200CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.65Profit Margin: -0.04
Financial Health
Altman Z-Score 9.46: safe zoneNotable
Altman Z-Score: 9.46
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Pihlajalinna Oyj
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanxi Huayang New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Hollyland China Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fujian Cement Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Pace Digitek Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
QC Solar Suzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Rechi Precision Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Beihai Gofar Chuangshan Biological Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shandong Hongyu Precision Manufacturing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Cynda Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Anhui Tatfook Technology Co., Ltd.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Finolex Industries Ltd.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Suzhou Electrical Apparatus Science Academy Co. Ltd.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity